🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Treatment Gaining Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to contact these profiles privately for source information, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Additionally, a robust trade exists on messaging services, where communities with thousands of participants share comparison images, administration instructions and assertions of rapid UK delivery. Sellers market the drug there before redirecting customers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Experts Voice Concerns

However, physicians and pharmacists have warned that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could lead to users injecting substances of uncertain source.

Several experts said the demand for retatrutide could be connected to the rising price of approved slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, advertising, and consumer laws, potentially leading to penalties, prosecution or prison.

Service Reaction and Material Elimination

Based on TikTok, the platform has taken down problematic content and prohibited related hashtags and search suggestions. The organization said it was committed to maintaining the service secure and allocating resources in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also discovered groups with up to 9,000 participants selling the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays groups with thousands of users, populated with photos of weight loss, positive reviews and step-by-step guides for mixing or injecting at home.

Within minutes of joining one group, a vendor shared WhatsApp details, where most purchases occur. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about body mass, medical conditions or past usage.

Product Information and Costs

Within these communities, messages display black plastic packages with postal service labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When asked how long a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Actions

A representative for the messaging service said it regularly monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting materials they can’t verify. Even if the science behind retatrutide is sound, these online products may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.

Her team has previously seen patients injured by self-injection from unverified sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject patients to potentially serious medical dangers”.